NASDAQ:SLRX
Delisted

Salarius Pharmaceuticals Stock Signals

etoro logo Buy SLRX
*Your capital is at risk
$0.84
+0 (+0%)
At Close: Apr 14, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Salarius Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 59 days ( 0 %
Last Price $0.84 0 %
Performance History
7 Days
$0.84 $0.84
0%
30 Days
$0.84 $0.84
0%
12 Mos
$0.680 $0.84
23.53%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.84 - $0.84
Trend - 3 mos -1.21 % High Width: 14.73 %
Pred. range - 3 mos $0.82 - $0.94 Low -2.55 % - 11.79 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 16, 2026 - 60 days
RSI Short Pivot Signal Buy Very Low Feb 04, 2026 - 48 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Feb 25, 2026 - 34 days
Short/Long MA 3 mos Sell Medium Feb 25, 2026 - 34 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.18
Signal Type Signal Value Importance Data
Trend - 12 mos -6.98 % Very High Width: 393.76 %
Pred. range - 12 mos N/A - $5.92 High -100.00 % - 604.84 %
Short MA 12 mos Sell Very High Feb 04, 2026 - 48 days
Long MA 12 mos Buy Very High Apr 06, 2026 - 7 days
Short/Long MA 12 mos Buy Very High Apr 06, 2026 - 7 days
Pivot Long Buy Low Jan 16, 2026 - 60 days
RSI Long Pivot Signal Buy Low Feb 13, 2026 - 41 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SALARIUS PHARMACEUTICALS INC.
Salarius Pharmaceuticals
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategi...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE